Your browser doesn't support javascript.
loading
Decreased biochemical progression in patients with castration-resistant prostate cancer using a novel mefenamic acid anti-inflammatory therapy: A randomized controlled trial.
Guzman-Esquivel, José; Mendoza-Hernandez, Martha A; Tiburcio-Jimenez, Daniel; Avila-Zamora, Oscar N; Delgado-Enciso, Josuel; De-Leon-Zaragoza, Luis; Casarez-Price, Juan C; Rodriguez-Sanchez, Iram P; Martinez-Fierro, Margarita L; Meza-Robles, Carmen; Barocio-Acosta, Alejandro; Baltazar-Rodriguez, Luz M; Zaizar-Fregoso, Sergio A; Plata-Florenzano, Jorge E; Delgado-Enciso, Iván.
Afiliación
  • Guzman-Esquivel J; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.
  • Mendoza-Hernandez MA; Department of Research, General Hospital of Zone No. 1 IMSS, Villa de Alvarez, Colima 28983, Mexico.
  • Tiburcio-Jimenez D; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.
  • Avila-Zamora ON; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.
  • Delgado-Enciso J; Department of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, Mexico.
  • De-Leon-Zaragoza L; Department of Research, Foundation for Cancer Ethics, Education and Research of The Cancerology State Institute, Colima 28085, Mexico.
  • Casarez-Price JC; Department of Research, General Hospital of Zone No. 1 IMSS, Villa de Alvarez, Colima 28983, Mexico.
  • Rodriguez-Sanchez IP; Department of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, Mexico.
  • Martinez-Fierro ML; Department of Research, General Hospital of Zone No. 1 IMSS, Villa de Alvarez, Colima 28983, Mexico.
  • Meza-Robles C; Department of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, Mexico.
  • Barocio-Acosta A; Molecular and Structural Physiology Laboratory, School of Biological Sciences, Autonomous University of Nuevo León, Monterrey, Nuevo León 64460, Mexico.
  • Baltazar-Rodriguez LM; Molecular Medicine Laboratory, Academic Unit of Human Medicine and Health Sciences, Autonomous University of Zacatecas, Zacatecas, Zacatecas 98160, Mexico.
  • Zaizar-Fregoso SA; Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.
  • Plata-Florenzano JE; Department of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, Mexico.
  • Delgado-Enciso I; Department of Research, Cancerology State Institute, Colima State Health Services, Colima 28085, Mexico.
Oncol Lett ; 19(6): 4151-4160, 2020 Jun.
Article en En | MEDLINE | ID: mdl-32391109
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Etiology_studies Aspecto: Patient_preference Idioma: En Revista: Oncol Lett Año: 2020 Tipo del documento: Article País de afiliación: México Pais de publicación: Grecia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Etiology_studies Aspecto: Patient_preference Idioma: En Revista: Oncol Lett Año: 2020 Tipo del documento: Article País de afiliación: México Pais de publicación: Grecia